GW&K Investment Management, LLC
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1082917
BOSTON, MA
Position in ARQT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$33,771,831
+$10,485,434 QoQ
Shares Held
1,288,018
+30.3% QoQ
Ownership
1.02%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#22
of 271 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $876,997,841 across 27 Biotechnology names. ARQT ranks #12 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
1,353,883 | $105,968,422 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
350,667 | $84,500,226 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,125,131 | $83,799,756 | |
| 4 | CYTK |
Cytokinetics Inc
|
916,107 | $78,043,155 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
246,883 | $78,037,246 | |
| 6 | VCEL |
Vericel Corp
|
1,550,497 | $68,981,610 | |
| 7 | INSM |
INSMED Inc
|
629,760 | $67,145,010 | |
| 8 | 1,731,140 | $64,779,258 |
All Filings in ARQT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,771,831 | 1,288,018 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $23,286,397 | 988,387 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $29,289,162 | 1,008,580 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $22,092,972 | 1,172,041 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $19,325,616 | 1,378,432 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $23,650,979 | 1,512,211 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $21,509,089 | 1,544,084 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $14,820,759 | 1,593,630 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $15,512,204 | 1,667,979 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $17,057,617 | 1,721,253 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $5,298,249 | 1,640,325 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $10,987,944 | 2,069,293 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $19,657,368 | 2,062,683 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $20,951,942 | 1,904,722 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $22,969,806 | 1,552,014 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $17,369,326 | 908,913 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $14,420,007 | 676,678 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,092,750 | 212,500 | Shares | Sole | 2022-05-09 | |
| No filing history on record for this holder in this stock. | ||||||